Opportunity Information: Apply for PA 21 110
Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional) is a National Institutes of Health (NIH) discretionary grant opportunity designed to help researchers and community partners do the early, practical work needed before launching larger, full-scale substance use prevention trials. The central goal is to fund pilot and feasibility studies that strengthen the evidence base and implementation readiness of prevention approaches, so that future, larger studies can be designed with more confidence about what works, for whom, and under what real-world conditions.
The FOA supports two broad types of projects. First, it funds the development and pilot testing of new interventions, as well as the adaptation and pilot testing of existing interventions, aimed at preventing or delaying the start of substance use and reducing the chance that early use escalates into misuse or a substance use disorder. Second, it supports pre-trial feasibility, acceptability, and readiness testing for services and service-system research that is relevant to substance use prevention. In practice, that can include work like testing recruitment and retention strategies, refining delivery methods, evaluating how acceptable an intervention is to participants and providers, assessing whether settings such as schools, clinics, or community organizations can realistically deliver the program, and identifying implementation barriers that could derail a later, larger trial.
While the main emphasis is prevention of substance use, misuse, and disorder, the NIH also highlights related outcomes that matter to public health and safety. Projects may focus on reducing negative downstream consequences associated with substance use, including deaths related to impaired driving, suicidal behavior (including both nonfatal and fatal attempts), and drug- or alcohol-related acquisition or transmission of HIV infection and viral hepatitis. The opportunity explicitly encourages work across diverse populations and settings, signaling interest in studies that are attentive to local context, equity, and the needs of communities that may face higher risk or fewer prevention resources.
This announcement uses the R34 mechanism and is labeled “Clinical Trial Optional,” meaning applicants can propose either projects that do not include a clinical trial or, if appropriate for the aims, projects that do include a clinical trial component. The funding instrument is a grant, and the activity area is listed under education and health. The CFDA number is 93.279, which corresponds to NIH research support in this topic space.
A wide range of organizations are eligible to apply. Eligible applicants include state, county, city, township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other entities. The FOA also calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, non-U.S. (foreign) organizations, regional organizations, tribal governments that are not federally recognized, and U.S. territories or possessions. This breadth is meant to encourage prevention research that is grounded in many kinds of institutions, including community-rooted organizations and settings where prevention can be delivered at scale.
Key administrative details from the listing include the funding opportunity number PA-21-110, an original closing date of 2024-01-07, and an award ceiling of $225,000. The opportunity was created on 2021-01-13. The listing does not specify the number of expected awards, suggesting it may vary depending on NIH priorities, availability of funds, and the quality of applications received.
Overall, the opportunity is best suited for teams that are not yet ready for a large, definitive prevention trial but have a strong concept that needs careful early testing. Competitive projects typically use the pilot period to finalize intervention content or delivery, demonstrate feasibility and acceptability, refine measures and procedures, and generate preliminary data that make a later, larger prevention trial more rigorous, realistic, and likely to succeed in real-world settings.Apply for PA 21 110
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2021-01-13.
- Applicants must submit their applications by 2024-01-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $225,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: NINDS Institutional Research Training Program (T32 - Clinical Trial Not Allowed)
Previous opportunity: HeartShare: Next Generation Phenomics to Define Heart Failure Subtypes and Treatment Targets Data Translation Center (U54 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 21 110
Applicants also applied for:
Applicants who have applied for this opportunity (PA 21 110) also looked into and applied for these:
| Funding Opportunity |
|---|
| Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed) Apply for RFA DA 22 004 Funding Number: RFA DA 22 004 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| High-throughput Discovery and Validation of Novel Signal Transducers or Small Molecules that Modulate Opioid or other Substance Use Disorder Relevant Pathways (R01 - Clinical Trials Not Allowed) Apply for RFA DA 22 006 Funding Number: RFA DA 22 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional) Apply for RFA CA 21 030 Funding Number: RFA CA 21 030 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advancing technologies to improve delivery of pharmacological, gene editing, and other cargoes for HIV and SUD mechanistic or therapeutic research (R01- Clinical Trial Optional) Apply for RFA DA 22 010 Funding Number: RFA DA 22 010 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Apply for PAR 21 190 Funding Number: PAR 21 190 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) Apply for PAR 21 318 Funding Number: PAR 21 318 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award (K22 - Independent Clinical Trial Required) Apply for PAR 21 111 Funding Number: PAR 21 111 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Apply for PAR 21 128 Funding Number: PAR 21 128 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Apply for PAR 21 061 Funding Number: PAR 21 061 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional) Apply for PAR 21 183 Funding Number: PAR 21 183 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 21 036 Funding Number: RFA CA 21 036 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NLM Institutional Grants for Research Training in Biomedical Informatics and Data Science (T15 Clinical Trial Not Allowed) Apply for RFA LM 21 001 Funding Number: RFA LM 21 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Apply for PAR 21 206 Funding Number: PAR 21 206 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,000 |
| Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) Apply for PAR 21 166 Funding Number: PAR 21 166 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,000 |
| Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional) Apply for PAR 21 208 Funding Number: PAR 21 208 Agency: National Institutes of Health Category: Education, Health Funding Amount: $150,000 |
| Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional) Apply for RFA AI 21 023 Funding Number: RFA AI 21 023 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 025 Funding Number: RFA AI 21 025 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 024 Funding Number: RFA AI 21 024 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Apply for RFA DA 22 002 Funding Number: RFA DA 22 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) Apply for PAR 21 213 Funding Number: PAR 21 213 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 21 110", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
